Alterity Therapeutics

Events and Presentations

<div class="ih-global-ui-overrides"></div>

<style>
  /* ==========================================================================
     InvestorHub Global UI Overrides
     Prefix: ih-
     Purpose:
       1) Hide share price / ticker widget
       2) Hide survey launcher button
       3) Hide injected timed survey popup panel
     ========================================================================== */

  /* --------------------------------------------------------------------------
     1) Hide ASX ticker / share price widget
     -------------------------------------------------------------------------- */
  #share-price {
    display: none !important;
    visibility: hidden !important;
    width: 0 !important;
    height: 0 !important;
    overflow: hidden !important;
  }

  #share-price + .h-8.w-px.bg-hubs-dividers {
    display: none !important;
  }

  /* --------------------------------------------------------------------------
     2) Hide the floating survey launcher button (bottom-right)
     (your earlier snippet)
     -------------------------------------------------------------------------- */
  .fixed.right-2.bottom-2.z-20.rounded-full.shadow-lg,
  .fixed.right-2.bottom-2.z-20 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* --------------------------------------------------------------------------
     3) Hide the timed/injected survey popup panel
     (the wrapper you pasted)
     -------------------------------------------------------------------------- */

  /* Extremely specific: matches the exact utility-class signature of that popup */
  .fixed.right-0.bottom-24.z-30.overflow-hidden.rounded-xl.shadow-xl.sm\:right-4.md\:bottom-4 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Slightly more flexible fallback (in case spacing classes change later)
     Still specific enough to avoid collateral damage */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Optional: if it ever mounts but stays in DOM, ensure it can't capture clicks */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 * {
    pointer-events: none !important;
  }
</style>

Publications & Presentations

The Science

Parkinsonian Diseases

Multiple System Atrophy

Pipeline

ATH434

About Us

Team

About Us Overview

Synapse Sessions

In The News

Media

Home

Contact Us

Analyst Coverage

Share Price

Announcements

Press Releases [2025]

Investor Overview

Governance

Investors

Montserrat

Neural Biotechs Twilight Investor Briefing - April 2026

American Academy of Neurology (AAN) Annual Meeting - April 2026

Bell Potter Healthcare Horizons Summit - March 2026

Bell Potter Healthcare Virtual Conference - November 2025

American Autonomic Society - November 2025

Maxim Healthcare Conference - October 2025

International Congress of Parkinson’s Disease and Movement Disorders (MDS) - October 2025

American Neurological Association (ANA) - September 2025

Biotech Showcase hosted by Peak Asset Management and Monsoon Communications - September 2025

19th Bioshares Biotech Summit - August 2025

Click here to view our most recent corporate presentation.

Key opinion leader (KOL) event featuring Roy Freeman, MD (Harvard Medical School, Beth Israel Deaconess Medical Center) and Daniel Claassen, MD, MS

(Vanderbilt University Medical Center), alongside David Stamler, MD, (CEO, Alterity Therapeutics), discussing the significant unmet need and current treatment landscape in Multiple System Atrophy (MSA), a rare, rapidly progressive neurodegenerative disease with no approved treatment.

Webcast Recordings